PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine

✍ Scribed by D. Novick; H. Ascher-Svanum; J. Bertsch; H. Detke; D. Mcdonnell; M. Witte; J. Haro

• Book ID: 119310165
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 71 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.08.314